405 results on '"Budd, G. Thomas"'
Search Results
2. Stereotactic Body Radiation Therapy for Sarcoma Pulmonary Metastases
3. A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
4. Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors
5. Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.
6. Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci
7. Supplementary Table S1 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
8. Supplementary Figure S5 from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
9. Data from Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
10. Neoadjuvant Reirradiation for Radiation Therapy–Associated Angiosarcoma of the Breast
11. Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
12. Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With Cancer
13. Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221
14. Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer
15. Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221
16. Genetic variations that influence paclitaxel pharmacokinetics and intracellular effects that may contribute to chemotherapy-induced neuropathy: A narrative review
17. Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer
18. Cardiac risk stratification in cancer patients: A longitudinal patient-patient network analysis
19. Impact of early detection on cancer curability: A modified Delphi panel study
20. The utility of repeated cytologic evaluation of cerebrospinal fluid in individuals with metastatic breast cancer
21. Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study
22. LATE-ONSET CHOROIDAL METASTASIS FROM BREAST CANCER
23. Metastatic Breast Carcinoma
24. Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancer
25. Delay to formalin fixation ‘cold ischemia time': effect on ERBB2 detection by in-situ hybridization and immunohistochemistry
26. Impact of Postmastectomy Radiation on Locoregional Recurrence in Breast Cancer Patients With 1-3 Positive Lymph Nodes Treated With Modern Systemic Therapy
27. Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)
28. Improved Surgical Outcomes for Breast Cancer Patients Receiving Neoadjuvant Aromatase Inhibitor Therapy: Results from a Multicenter Phase II Trial
29. A phase II pharmacodynamic study of pyrazoloacridine in patients with metastatic colorectal cancer
30. Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer
31. The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
32. Abstract PS12-16: Pilot study of carboplatin, nab-paclitaxel and pembrolizumab for metastatic triple-negative breast cancer
33. Abstract PS12-18: Efficacy of everolimus and exemestane for the treatment of metastatic hormone receptor-positive breast cancer in patients previously treated with CDK4/6 inhibitors
34. Phase 1 trial of Anvirzel™ in patients with refractory solid tumors
35. Neratinib for Extended Anti-HER2 Therapy in Early Breast Cancer
36. Phase I trial of vinorelbine and diphenylhydantoin in patients with refractory carcinoma
37. Metronomic therapy for breast cancer
38. Impact of timing of atrial fibrillation, CHA2DS2-VASc score and cancer therapeutics on mortality in oncology patients
39. Incidence and outcomes of cutaneous angiosarcoma: A SEER population-based study
40. Circulating tumor cells, disease progression, and survival in metastatic breast cancer
41. Management of angiosarcoma
42. Biochemical Modulation of 5-Fluorouacil Through Dihydropyrimidine Dehydrogenase Inhibition: a Southwest Oncology Group Phase II Trial of Eniluracil and 5-Fluorouracil in Advanced Resistant Colorectal Cancer
43. Phase II Trial of Topotecan by Continuous Infusion in Patients with Advanced Soft Tissue Sarcomas, a SWOG Study
44. Real-World Outcomes of Everolimus and Exemestane for the Treatment of Metastatic Hormone Receptor-Positive Breast Cancer in Patients Previously Treated With CDK4/6 Inhibitors.
45. Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival
46. Abstract P2-14-13: Comparison of survival outcomes between treatment with endocrine therapy and chemoendocrine therapy in patients with invasive lobular carcinoma
47. Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer
48. Can CDK4/6 inhibitors cause fatal lung injury?
49. Unusual macular degeneration following breast cancer
50. Novel Prognostic Immunohistochemical Biomarker Panel for Estrogen Receptor–Positive Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.